Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.5K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.5K
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

3.4K
Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
3.4K
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

2.7K
Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
2.7K
The Cardiac Cycle01:13

The Cardiac Cycle

98.3K
The heart beats rhythmically in a sequence called the cardiac cycle—a rapid coordination of contraction (systole) and relaxation (diastole).
The Process
Electrical signals—sent from the sinoatrial (SA) node in the right atrial wall to the atrioventricular (AV) node between the right atrium and right ventricle—cause both atria to simultaneously contract. When the signal reaches the AV node, it pauses for approximately a tenth of a second, allowing the atria to contract and...
98.3K
Cardiac Cycle01:29

Cardiac Cycle

13.0K
The cardiac cycle refers to the sequence of events that occur in the heart from the beginning of one heartbeat to the next. It's characterized by alternating periods of contraction (systole) and relaxation (diastole) of the heart muscles.
During the cardiac cycle, blood flow through the heart is regulated entirely by changing pressure gradients. This sequence of events begins with the heart in a state of total relaxation, known as mid-to-late diastole, during which blood passively flows from...
13.0K
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

2.0K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrograde Migration of a Percutaneous Endoscopic Gastro-Jejunal Tube Into the Esophagus.

Cureus·2024
Same author

Successful Treatment of Balamuthia mandrillaris Granulomatous Amebic Encephalitis with Nitroxoline.

Emerging infectious diseases·2022
Same author

Hospice Emergency Planning and COVID-19.

Journal of palliative care·2021
Same author

NOR-1 distinguishes acinic cell carcinoma from its mimics on fine-needle aspiration biopsy specimens.

Human pathology·2020
Same author

Myxedema Coma Complicated by Pancytopenia.

Case reports in medicine·2019
Same author

Case Report: Monoclonal Gammopathy of Undetermined Significance is Associated with

The American journal of tropical medicine and hygiene·2018

Related Experiment Video

Updated: Feb 6, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.4K

Cardiac Involvement by HIV-Associated DLBCL.

Charles T Mupamombe1, Jude Noel2, Derek B Laskar3

  • 1Department of Internal Medicine, STAR Clinic, SUNY Downstate Medical Center, Brooklyn, NY, USA.

Case Reports in Medicine
|August 30, 2018
PubMed
Summary

Diffuse large B-cell lymphoma (DLBCL) is a common cancer in people with HIV. Cardiac involvement is rare but indicates aggressive disease, with tachycardia and dysphagia as potential symptoms.

More Related Videos

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.2K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

32.2K

Related Experiment Videos

Last Updated: Feb 6, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.4K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.2K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

32.2K

Area of Science:

  • Oncology
  • Infectious Diseases
  • Cardiology

Background:

  • Non-Hodgkin's lymphoma (NHL) is an AIDS-defining cancer, with diffuse large B-cell lymphoma (DLBCL) being the most prevalent type.
  • While DLBCL prognosis has improved in the general population, it remains challenging in HIV-positive individuals.
  • Cardiac involvement in DLBCL is uncommon but signifies aggressive disease progression.

Observation:

  • This case report details a patient with HIV experiencing DLBCL with cardiac involvement.
  • The patient presented with tachycardia and dysphagia as the sole indicators of cardiac compromise.
  • This highlights the subtle clinical presentation of rare cardiac manifestations in HIV-associated DLBCL.

Findings:

  • Diffuse large B-cell lymphoma (DLBCL) can manifest with cardiac involvement in HIV-positive patients.
  • Tachycardia and dysphagia were the presenting symptoms, suggesting potential cardiac infiltration.
  • This case underscores the importance of considering cardiac involvement in HIV-DLBCL, even with atypical symptoms.

Implications:

  • Early recognition of cardiac involvement in HIV-DLBCL is crucial for timely intervention.
  • Tachycardia and dysphagia may serve as early warning signs for cardiac compromise in this patient population.
  • Further research is needed to understand the mechanisms and optimal management of cardiac DLBCL in HIV-infected individuals.